Redefining Immunotherapy
Our Science
Innovation
At Rise Therapeutics, we pioneer precision immunotherapy by integrating new immunological discoveries and advanced oral drug delivery approaches to transform immunotherapy drug development. Our synthetic biology-based rational drug design approach drives the development of targeted first-in-class Oral Immune BioModulators, now evolving through clinical validation studies for the treatment of autoimmunity and cancer.
Immunology
Unlocking immune programming
Rise Therapeutics` Oral Immune BioModulators control and direct immune programming to reset immunological repertoires and correct the root cause of disease. Our products represent a paradigm shift in immunotherapy product development—harnessing foundational immune controls as a gateway to modulate systemic immune function with unprecedented specificity and control.
Read more
From Science to Patients
Orchestrating Immune Response
Dendritic cells are master regulators of immune function and by directing these immune cell populations via our Oral Immune Biomodulators, we articulate the genesis of selected immune populations that have the potential to correct immunological dysfunction that can cause disease. We validate our dendritic cell targets and their modulators, confirming safety in non-clinical studies, before we evaluate in patients to determine disease improvement mediated by our therapy products.
Read more
Read more
Synthetic Biology
Targeted, oral drug delivery
As a foundational technology, Rise Therapeutics has developed an innovative and proprietary drug delivery platform that embraces synthetic biology-based approaches to enable oral delivery of targeted biologic therapy. We leverage this proprietary platform for convenient oral capsule administration of our Oral Immune BioModulator products.
Read more
Read more
Our Capabilities
INFRASTRUCTURE
Clinical GMP
Manufacturing
Rise Therapeutics integrates regulatory expertise with clinical development and in-house,
state-of-the-art clinical GMP manufacturing, ensuring seamless translation from discovery to
patient-ready immunotherapies
with the highest quality
standards.
CLINICAL TRANSLATION
Product Development
Backed by robust preclinical data, Rise Therapeutics’ Oral BioModulators are advancing through clinical validation studies across multiple indications, offering patients a safe, first-in-class approach to correct underlying immune dysfunction that contributes to disease.
Our Pipeline
At Rise Therapeutics, we drive rapid and efficient drug development by integrating cutting-edge research, in-house GMP manufacturing, and deep clinical and regulatory expertise. Our streamlined approach enables us to translate innovative laboratory discoveries into first-in-class oral immunotherapies, accelerating their journey from concept to clinical validation. By leveraging our proprietary oral drug delivery platform and end-to-end development capabilities, we are advancing a robust pipeline of next-generation immunotherapies for the treatment of autoimmune diseases and cancer.
Our Team
Interested in working with Us?
Become a Partner
Rise Therapeutics seeks strategic partnerships with academic, biotech, and pharmaceutical leaders committed to advancing groundbreaking immunotherapies and transforming patient care.
Read more
Read more
Join Our Team
We are always looking for extraordinary people with exceptional creativity and enthusiasm. In our collaborative, high performing, and entrepreneurial environment, we work as a team to investigate life saving products and treatments.
Read more
Read more